l‐α‐Lysophosphatidylinositol (LPI) aggravates myocardial ischemia/reperfusion injury via a GPR55/ROCK‐dependent pathway

The phospholipid l‐α‐lysophosphatidylinositol (LPI), an endogenous ligand for GPR55, is elevated in patients with acute coronary syndrome, and a GPR55 antagonist cannabidiol (CBD) reduces experimental ischemia/reperfusion (I/R) injury. While LPI activates multiple signaling pathways, little is known...

Descripción completa

Detalles Bibliográficos
Autores principales: Robertson‐Gray, Olivia J., Walsh, Sarah K., Ryberg, Erik, Jönsson‐Rylander, Ann‐Cathrine, Lipina, Christopher, Wainwright, Cherry L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533556/
https://www.ncbi.nlm.nih.gov/pubmed/31149342
http://dx.doi.org/10.1002/prp2.487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533556/
https://www.ncbi.nlm.nih.gov/pubmed/31149342
http://dx.doi.org/10.1002/prp2.487

Ejemplares similares